Navigation Links
Nektar Therapeutics Reports Financial Results for the Second Quarter of 2014
Date:7/31/2014

ws_span">(77,711)Non-operating income (expense):Interest income 132209266523Interest expense(4,488)(4,656)(9,021)(9,301)Non-cash interest expense on liability related to sale of future royalties

(5,134)(5,485)(10,521)(11,028)Other income (expense), net(36)(6)142123Total non-operating expense, net

(9,526)(9,938)(19,134)(19,683)Loss before provision for income taxes

(32,442)(42,543)(78,452)(97,394)Provision for income taxes195205386417Net loss$
(32,637)
$
(42,748)
$
(78,838)
$
(97,811)
Basic and diluted net loss per share

$
(0.26)
$
(0.37)
$
(0.63)
$
(0.85)
Weighted average shares outstanding used in computing basic and diluted net loss per share

127,040115,544'/>"/>

SOURCE Nektar Therapeutics
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nektar to Announce Financial Results for the Second Quarter 2014 on Thursday, July 31, 2014, After Close of U.S.-Based Financial Markets
2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
4. Nektar to Announce Financial Results for the Third Quarter of 2013 on Thursday, November 7, 2013, After Close of U.S.-Based Financial Markets
5. Nektar Reports that Partner AstraZeneca Announced European Medicines Agency Acceptance of Marketing Authorisation Application for Naloxegol
6. Nektar Therapeutics Reports Financial Results for the Second Quarter of 2013
7. Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of U.S.-Based Financial Markets
8. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
9. Nektar Therapeutics Presents Positive Data from Human Abuse Liability Study for NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at 2013 Annual Meeting of The College on Problems of Drug Dependence
10. Nektar Presents Positive Preclinical Data for NKTR-214, a Novel Cancer Immunotherapy, At the 2013 American Society of Clinical Oncology Annual Meeting
11. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... August 31, 2015 A ... global cardiovascular monitoring and diagnostic devices market stood ... to reach a value of approximately US$7.0 billion ... between 2013 and 2019. The title of the ... (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, ...
(Date:8/31/2015)... 31, 2015  Regulatory affairs professionals work at ... are often strict and legislation is ever-changing. The ... for professionals who have a deep understanding of ... product lifecycle and demonstrate its use across various ... California, Irvine Extension , in partnership with the ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. ... SNY ; EURONEXT: SAN) and the life sciences ... to improve care and outcomes for people with type ... in diabetes treatments and devices with Google,s expertise in ... companies will explore how to improve diabetes care by ...
Breaking Medicine Technology:Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
(Date:8/31/2015)... (PRWEB) , ... September 01, 2015 , ... ... professionals, today announced the release of ten hours of new premium on-demand video ... of Certification members. , Athletic Trainers certified before 2014 must complete 50 CEUs ...
(Date:8/31/2015)... ... September 01, 2015 , ... Spinal fusion surgery ... once required a long, arduous recovery. However, today’s minimally invasive fusions achieve similar ... loss and minimal muscle damage. These advantages of minimally invasive surgery redeem the ...
(Date:8/31/2015)... ... August 31, 2015 , ... Sculpted Contours Luxury Medical ... Women of Power and Influence by Modern Luxury’s The Atlantan Magazine. , ... as well as Kathy King. Her idea and vision to bring to Atlanta ...
(Date:8/31/2015)... Thousand Oaks, CA (PRWEB) , ... August 31, ... ... has recently been updated to include a wealth of information for specific translation ... Translations has great expertise and an incredible track record of successful work. , ...
(Date:8/31/2015)... ... , ... Southern Vacation Rentals – a member of the locally owned and ... property management company, 360 Blue, in support of the Sonder Project, a global ... two companies will collect any unopened food items left in vacation rentals after guest ...
Breaking Medicine News(10 mins):Health News:Evidence Based Practice Courses: CEUs For Athletic Trainers Just Released 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 2Health News:Sculpted Contours Owner Selected One of Atlanta's Women of Power and Influence by Modern Luxury's The Atlantan Magazine 3Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3Health News:Southern Vacation Rentals Partners with the Sonder Project 2Health News:Southern Vacation Rentals Partners with the Sonder Project 3
... (Oct. 31, 2007) -- High-blood-pressure patients treated for ... regression or prevention of LVH may also have ... physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the ... journal of the American Heart Association (AHA). , ...
... The Medicare bidding,program for durable medical equipment ... infrastructure" unless Congress modifies,the program. This is the ... subcommittee today by the American Association for Homecare.,The ... of care, choice of provider, and access to ...
... Oct. 31 MGT Capital Investments,Inc. (Amex: MGT ... sector, announced today that it plans to present at ... at the New York,Palace Hotel, in New York City ... Tim Paterson-Brown, Chairman and CEO of MGT Capital Investments, ...
... in ... resistance, ... pharmaceutical company dedicated to the discovery, rapid,development and commercialization of therapies ... at,the American Society for Therapeutic Radiology and Oncology,s (ASTRO) 49th,Annual Meeting ...
... Mass., Oct. 31 Coley,Pharmaceutical Group, Inc. (Nasdaq: ... Ph.D., Coley,s President and Chief Executive Officer, plans ... Acumen BioFin Rodman &,Renshaw 9th Annual Healthcare Conference ... New York Palace Hotel. Interested parties may ...
... LOS ANGELES, Oct. 31 Response Genetics, Inc.,(Nasdaq: ... Danenberg,will provide a business overview, including an update on ... at the BIOCOM Investor Conference at the San Diego ... 2. Ms. Danenberg will present at,5:30 p.m. PT Thursday, ...
Cached Medicine News:Health News:Preventing or reducing enlarged heart may decrease risk for diabetes 2Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 2Health News:Medicare Bidding for Durable Medical Equipment Will Harm Small Businesses and Seniors' Access to Care, American Association for Homecare Testifies 3Health News:MGT Capital Investments to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2Health News:Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme 2Health News:Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme 3Health News:Response Genetics Announces Presentation/Webcast at BIOCOM Investor Conference 2
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
... biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed ... cornea., ,The World Health Organisation (WHO) reports ... million people worldwide, however only 100,000 people ... is due to a combination of inadequate ...
PDA-version of the complete ICD-9 diagnosis codes....
PDA formatted guide containing outlines and detailed information on the diagnosis and treatment of HIV infection and AIDS....
Medicine Products: